Hello There!

I am Dr. Akanand Singh, a pioneer in liver transplant and hepatobiliary surgery in Nepal.

Information

Appointment

testng

Portal Hyperperfusion Index Liver Transplant Study

Dr Akanand Singh liver transplant surgeon Nepal
Dr Akanand Singh – Liver Transplant Surgeon and Associate Professor at KIST Medical College & Teaching Hospital

Introduction to Portal Hyperperfusion Index Liver Transplant Study

The Portal Hyperperfusion Index Liver Transplant study focuses on understanding the impact of portal hyperperfusion on early allograft dysfunction (EAD). Portal hyperperfusion is a critical factor that can negatively affect graft survival after liver transplantation. Identifying patients who require portal inflow modulation is essential to improve surgical outcomes and patient survival.


Understanding the Study and Methodology

This study analyzed 135 adult living donor liver transplant recipients between September 2016 and July 2020. A test cohort of 96 patients and a validation cohort of 39 patients were used. Researchers developed the Hyperperfusion Index (HPi), calculated using post-transplant portal pressure gradient and graft-to-recipient splenic volume ratio (GRSVR), based on flow dynamics and regression analysis.


Key Findings of Portal Hyperperfusion Index

Results showed that 29.6% of patients developed EAD, with a mortality rate of 4.4%. Patients with EAD had lower GRSVR and higher portal pressure gradients. The Portal Hyperperfusion Index Liver Transplant model demonstrated strong predictive ability.

  • HPi ≥ 9.97 predicted EAD with 90% sensitivity

  • HPi ≥ 16.25 predicted 90-day mortality with high accuracy

  • Higher HPi was associated with delayed graft recovery

Patients without EAD showed significantly better survival rates at 1-year and 2-year follow-ups.


Clinical Importance and Applications

The Portal Hyperperfusion Index Liver Transplant approach helps surgeons identify high-risk patients during surgery. While preoperative GRSVR provides early indications, intraoperative HPi offers more precise prediction. Maintaining HPi below critical thresholds can significantly reduce complications.


Visual Understanding (Suggested Images)

https://images.openai.com/static-rsc-3/TLiNnhjovQULiGw_a1B07N3oMralJW6Q8JqRbluALD8KYJRZBO5QGFQqXHaKFclhu6aqLWUS2NZjpyFTx9BoW2BPh39uT31WxDCdLqp40cQ?purpose=fullsize&v=1
https://images.openai.com/static-rsc-3/JoNsjPfsb6qmcWmu494jtJWAjvf5WtIxjHkX_ySeqmZFCXf-OlIKSWIgvLRuJyNdXJWnWKNd1uF1lJgHcB3CipHvOy4ffLsNeAEgmkAnSck?purpose=fullsize&v=1https://images.openai.com/static-rsc-3/uZsFiPEdwmwk_qtr-tGejLrRe8lyB2HwK2XH3MpJs_NQPCCMjEg-qfT5eGF_IDpFSoTBl_7fxhn2Qg3Rz1zWNKLnwhZVUfgsvPSjcazWnPg?purpose=fullsize&v=1

Example:


Learn More 


External References

For detailed research, visit PubMed or explore global health insights from World Health Organization.


Conclusion

The Portal Hyperperfusion Index Liver Transplant study provides a valuable predictive tool for improving transplant outcomes. By identifying high-risk patients and applying timely interventions, clinicians can significantly enhance graft survival and reduce mortality rates.